Business · 22/11/2010
FDA Approves New Dosage Form for Cloxacillin Benzathine Animal Drug
The US Food and Drug Administration (FDA) has amended animal drug regulations to reflect approval of a supplementary new animal drug application (NADA) filed by Boehringer Ingelheim Vetmedica, Inc., which includes minor revisions to labeling for the antibiotic cloxacillin benzathine.
Original source language: Federal Register — Health and Human ServicesOpen original release →